GlycA (Glycoprotein Acetylation)
GlycA (Glycoprotein Acetylation) is a clinical biomarker on the Inflammation panel, reported in µmol/L. Standard reference range: 300–450 µmol/L. Functional (optimal) range used by integrative practitioners: 300–380 µmol/L.
What is GlycA (Glycoprotein Acetylation)?
GlycA is an NMR-derived composite signal reflecting glycosylated acute-phase proteins (including alpha-1-acid glycoprotein, haptoglobin, and alpha-1-antitrypsin), offering a more stable, integrative measure of chronic low-grade inflammation than hs-CRP.
Reference ranges
| Range type | Value (µmol/L) | Source |
|---|---|---|
| Standard (lab) | 300–450 | Typical Quest / LabCorp adult reference |
| Functional (optimal) | 300–380 | Integrative / functional medicine consensus |
How SomaVue interprets GlycA (Glycoprotein Acetylation)
SomaVue maps every result for GlycA (Glycoprotein Acetylation) against four clinical lenses — nutrient cofactors, toxin exposure, infection drivers, and circadian/hormonal context — and connects each interpretation to specific peer-reviewed citations. Pre-mapped clinical reasoning and cross-marker pattern detection are available inside the practitioner workspace.
See the full interpretation
Upload a patient PDF from Quest, LabCorp, Access Medical Labs, LifeLabs, Vibrant, Rupa, or any other lab — or enter values manually. See the four-lens analysis, cross-marker patterns, and cited evidence for GlycA (Glycoprotein Acetylation) and 223 other markers.
Try it freeEducational reference only. Reference ranges vary by laboratory, assay method, age, sex, and clinical context. Functional ranges represent integrative-medicine consensus and are not regulatory thresholds. SomaVue does not diagnose, treat, mitigate, or prevent disease. Always consult a licensed healthcare provider.